WhiteLab Genomics
A biotech company using AI to design and validate genomic medicines and delivery vehicles.
WhiteLab Genomics is a biotech & life sciences company based in Paris, FR, founded in 2019. It has raised $26.14 million in disclosed funding. Its latest round was a Series B of €23.2 million in October 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $26.1M across 1 round. Computed only from sourced rounds.
| Date | Company | Amount | Stage | Lead | Other investors | Sector | Sources |
|---|---|---|---|---|---|---|---|
| €23.2M | Series B | AVP | Yaday Health +3 | Biotech & Life Sciences | 1 |
- WhiteLab Genomics€23.2M
Led by AVP · with Yaday Health, +3
Investors
Questions and answers
What does WhiteLab Genomics do?
A biotech company using AI to design and validate genomic medicines and delivery vehicles.
How much has WhiteLab Genomics raised?
WhiteLab Genomics has raised $26.14 million in disclosed funding across 1 round tracked by OSH.
Who has invested in WhiteLab Genomics?
Investors in WhiteLab Genomics include AVP, Yaday Health, Blast Club, Omnes Capital, and Debiopharm Innovation Fund.
When and where was WhiteLab Genomics founded?
WhiteLab Genomics was founded in 2019 and is based in Paris, FR.
Timeline
Founded
Sources
- 1.Paris-based WhiteLab Genomics raises €23.2 million to accelerate AI-driven genomic medicine development — EU-Startups, Oct 6, 2026